Recce scores US$2M deal from US Department of Defense for burn wound infections gel
Synthetic anti-infective developer Recce Pharmaceuticals Ltd (ASX:RCE) has made inroads for recognition…
Recce Pharmaceuticals Ltd (ASX:RCE)
About Recce Pharmaceuticals Ltd
Key Information
RCE In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 26/07/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 926.64KB | 920 |
| 15/07/2024 | Price Sensitive PS US Department of Defense Grants US $2m for R327G | 346.08KB | 4.6K |
| 11/07/2024 | Change of Auditor | 181.17KB | 355 |
| 10/07/2024 | Share Purchase Plan - Letter and Offer Booklet | 813.71KB | 496 |
| 09/07/2024 | Cleansing Notice | 212.8KB | 274 |
| 09/07/2024 | Application for quotation of securities - RCE | 15.85KB | 282 |
| 08/07/2024 | Price Sensitive PS R327 Efficacy against WHO Priority Pathogen Acinetobacter B | 504.85KB | 5.7K |
| 02/07/2024 | Equity Raising Presentation | 2.96MB | 770 |